One-stage vs two-stage bilateral THA in Lombardy: a cost-effectiveness analysis

Pierluigi Pironti,Andrea Ambrosanio,Valeria Vismara,Marco Viganò,Eugenia Bucci,Paolo Sirtori,Giuseppe M Peretti,Laura Mangiavini
DOI: https://doi.org/10.1186/s12962-023-00418-y
2023-01-17
Cost Effectiveness and Resource Allocation
Abstract:Total hip arthroplasty (THA) is the most common treatment for primary and secondary end-stage hip osteoarthritis (OA). Almost 20% of all patients undergoing primary THA suffer from bilateral hip OA and, consequently, will need a contralateral procedure to be performed in the following years. The aim of this study is to evaluate the cost-effectiveness and the reliability of one-stage bilateral THA (1-BTHA) compared to two-stage bilateral THA (2-BTHA), in low-risk patients, performed with anterior minimally invasive surgery (AMIS).
health policy & services
What problem does this paper attempt to address?